DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma (2018)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1089/thy.2018.29065.abstracts
- Subjects: NEOPLASIAS DA TIREOIDE; DNA
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Annual Meeting of the American Thyroid Association
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
BHAN, A. et al. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma. Thyroid. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1089/thy.2018.29065.abstracts. Acesso em: 27 dez. 2025. , 2018 -
APA
Bhan, A., Mosella, M. S., Singer, M., Keller, C. E., Shaar, R. A., Chang, S., et al. (2018). DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma. Thyroid. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1089/thy.2018.29065.abstracts -
NLM
Bhan A, Mosella MS, Singer M, Keller CE, Shaar RA, Chang S, Wu V, Stephen J, Worsham M, Noushmehr H. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma [Internet]. Thyroid. 2018 ; 28 A-24.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1089/thy.2018.29065.abstracts -
Vancouver
Bhan A, Mosella MS, Singer M, Keller CE, Shaar RA, Chang S, Wu V, Stephen J, Worsham M, Noushmehr H. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma [Internet]. Thyroid. 2018 ; 28 A-24.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1089/thy.2018.29065.abstracts - Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes
- Molecular patterns at regulatory elements diferentially methylated in glioma
- Clinical data that matters: a distillation of neuro-oncology clinical trial inclusion criteria using machine learning
- Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication
- Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma
- DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
- SpidermiR: an R/Bioconductor package for integrative analysis with miRNA data
- Epigenomic glioma subtype evaluation across 31 tumor types
Informações sobre o DOI: 10.1089/thy.2018.29065.abstracts (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
